Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Herniorrhaphy | 6 | 2021 | 26 | 2.500 |
Why?
|
Hernia, Ventral | 3 | 2021 | 10 | 2.040 |
Why?
|
Accidents, Traffic | 3 | 2020 | 117 | 1.300 |
Why?
|
Hernia, Inguinal | 4 | 2021 | 19 | 1.260 |
Why?
|
Insurance Coverage | 5 | 2018 | 108 | 1.070 |
Why?
|
Child Mortality | 2 | 2020 | 13 | 0.800 |
Why?
|
Hernia, Femoral | 1 | 2021 | 1 | 0.790 |
Why?
|
Hernia, Umbilical | 1 | 2021 | 18 | 0.780 |
Why?
|
Watchful Waiting | 1 | 2019 | 29 | 0.680 |
Why?
|
Health Services Accessibility | 3 | 2016 | 427 | 0.630 |
Why?
|
Motor Vehicles | 1 | 2017 | 20 | 0.600 |
Why?
|
Child Restraint Systems | 1 | 2017 | 26 | 0.600 |
Why?
|
Gastric Outlet Obstruction | 1 | 2016 | 6 | 0.580 |
Why?
|
Anti-HIV Agents | 5 | 2010 | 43 | 0.570 |
Why?
|
Time-to-Treatment | 1 | 2017 | 74 | 0.570 |
Why?
|
Pyloric Stenosis, Hypertrophic | 1 | 2016 | 29 | 0.560 |
Why?
|
Emergency Medical Services | 1 | 2017 | 126 | 0.550 |
Why?
|
HIV Infections | 6 | 2010 | 394 | 0.520 |
Why?
|
Esophageal Neoplasms | 2 | 2016 | 100 | 0.520 |
Why?
|
Hospital Mortality | 2 | 2018 | 466 | 0.500 |
Why?
|
Patient Selection | 1 | 2016 | 284 | 0.500 |
Why?
|
Adolescent | 14 | 2021 | 6896 | 0.480 |
Why?
|
Esophageal and Gastric Varices | 1 | 2012 | 12 | 0.430 |
Why?
|
Laparoscopy | 3 | 2020 | 186 | 0.420 |
Why?
|
Endoscopy, Digestive System | 1 | 2012 | 53 | 0.420 |
Why?
|
Cost-Benefit Analysis | 6 | 2019 | 291 | 0.420 |
Why?
|
Male | 23 | 2021 | 27335 | 0.400 |
Why?
|
Child, Preschool | 9 | 2021 | 4161 | 0.400 |
Why?
|
Quality Improvement | 3 | 2019 | 245 | 0.400 |
Why?
|
Female | 22 | 2021 | 28457 | 0.380 |
Why?
|
Infant | 8 | 2021 | 3832 | 0.380 |
Why?
|
Child | 11 | 2021 | 7372 | 0.370 |
Why?
|
Databases, Factual | 5 | 2020 | 683 | 0.360 |
Why?
|
United States | 12 | 2020 | 5204 | 0.320 |
Why?
|
Trauma Centers | 2 | 2020 | 216 | 0.310 |
Why?
|
Adult | 14 | 2019 | 14189 | 0.300 |
Why?
|
Humans | 28 | 2021 | 54304 | 0.290 |
Why?
|
Incidence | 6 | 2021 | 1083 | 0.270 |
Why?
|
Prevalence | 3 | 2021 | 1026 | 0.250 |
Why?
|
Appendectomy | 2 | 2020 | 41 | 0.230 |
Why?
|
Retrospective Studies | 6 | 2021 | 6462 | 0.230 |
Why?
|
Wounds and Injuries | 2 | 2018 | 320 | 0.230 |
Why?
|
Odds Ratio | 4 | 2020 | 600 | 0.230 |
Why?
|
Logistic Models | 3 | 2016 | 991 | 0.230 |
Why?
|
Middle Aged | 11 | 2019 | 13076 | 0.220 |
Why?
|
Treatment Outcome | 4 | 2019 | 5609 | 0.220 |
Why?
|
Follow-Up Studies | 3 | 2018 | 2389 | 0.220 |
Why?
|
Young Adult | 6 | 2019 | 4313 | 0.210 |
Why?
|
Groin | 1 | 2021 | 16 | 0.200 |
Why?
|
Abdominal Wall | 1 | 2021 | 10 | 0.200 |
Why?
|
Risk Factors | 5 | 2018 | 3934 | 0.190 |
Why?
|
Drug Prescriptions | 1 | 2020 | 89 | 0.180 |
Why?
|
Infant, Newborn | 4 | 2021 | 2923 | 0.180 |
Why?
|
Pain, Postoperative | 1 | 2020 | 160 | 0.180 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2009 | 41 | 0.180 |
Why?
|
Aged | 5 | 2019 | 10054 | 0.180 |
Why?
|
Confidence Intervals | 2 | 2016 | 166 | 0.170 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2016 | 62 | 0.170 |
Why?
|
Battered Child Syndrome | 1 | 2018 | 1 | 0.170 |
Why?
|
Splenic Diseases | 1 | 2018 | 7 | 0.170 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 78 | 0.170 |
Why?
|
Aged, 80 and over | 3 | 2016 | 3430 | 0.160 |
Why?
|
Testicular Diseases | 1 | 2018 | 4 | 0.160 |
Why?
|
Societies, Medical | 1 | 2019 | 197 | 0.160 |
Why?
|
Splenectomy | 1 | 2018 | 35 | 0.160 |
Why?
|
Cohort Studies | 3 | 2020 | 1547 | 0.160 |
Why?
|
Risk Assessment | 3 | 2016 | 1361 | 0.150 |
Why?
|
Pylorus | 1 | 2016 | 3 | 0.150 |
Why?
|
Malawi | 2 | 2016 | 11 | 0.140 |
Why?
|
Quality of Health Care | 1 | 2018 | 218 | 0.140 |
Why?
|
Medically Uninsured | 1 | 2016 | 51 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 4 | 2010 | 35 | 0.140 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 82 | 0.140 |
Why?
|
Emergencies | 1 | 2016 | 92 | 0.140 |
Why?
|
Patient Admission | 1 | 2016 | 78 | 0.140 |
Why?
|
Age Factors | 2 | 2016 | 1200 | 0.140 |
Why?
|
Insurance, Health | 1 | 2016 | 132 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 500 | 0.140 |
Why?
|
Abdominal Pain | 1 | 2016 | 84 | 0.130 |
Why?
|
Patient Safety | 1 | 2016 | 121 | 0.130 |
Why?
|
Time Factors | 3 | 2018 | 3207 | 0.130 |
Why?
|
Appendicitis | 1 | 2016 | 77 | 0.130 |
Why?
|
Sepsis | 1 | 2018 | 250 | 0.130 |
Why?
|
General Surgery | 1 | 2016 | 113 | 0.130 |
Why?
|
Computer Simulation | 4 | 2010 | 329 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2016 | 1083 | 0.120 |
Why?
|
Transcriptome | 1 | 2016 | 346 | 0.120 |
Why?
|
Medicaid | 1 | 2016 | 267 | 0.120 |
Why?
|
Sex Factors | 1 | 2016 | 766 | 0.120 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 1044 | 0.110 |
Why?
|
Healthcare Disparities | 1 | 2016 | 270 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 385 | 0.110 |
Why?
|
Hospitals, Public | 1 | 2012 | 9 | 0.110 |
Why?
|
Health Care Costs | 3 | 2009 | 176 | 0.100 |
Why?
|
Postoperative Complications | 1 | 2018 | 1035 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2012 | 643 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2012 | 307 | 0.090 |
Why?
|
Survival Analysis | 2 | 2007 | 736 | 0.080 |
Why?
|
Income | 2 | 2020 | 102 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2010 | 181 | 0.080 |
Why?
|
Caribbean Region | 1 | 2007 | 4 | 0.080 |
Why?
|
Cost of Illness | 1 | 2007 | 132 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2007 | 40 | 0.070 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 1693 | 0.070 |
Why?
|
Poisson Distribution | 2 | 2020 | 32 | 0.070 |
Why?
|
Patient Compliance | 1 | 2006 | 247 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 540 | 0.060 |
Why?
|
Mass Screening | 1 | 2007 | 366 | 0.060 |
Why?
|
Markov Chains | 2 | 2017 | 34 | 0.060 |
Why?
|
Melanoma | 1 | 2007 | 313 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 2 | 2017 | 70 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2009 | 922 | 0.050 |
Why?
|
Small-Area Analysis | 1 | 2020 | 7 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2007 | 532 | 0.050 |
Why?
|
Constipation | 1 | 2020 | 36 | 0.050 |
Why?
|
Local Government | 1 | 2020 | 25 | 0.050 |
Why?
|
Sex Distribution | 1 | 2020 | 158 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2020 | 125 | 0.050 |
Why?
|
Life Expectancy | 2 | 2010 | 39 | 0.040 |
Why?
|
Urban Population | 1 | 2020 | 182 | 0.040 |
Why?
|
Educational Status | 1 | 2020 | 261 | 0.040 |
Why?
|
Scoliosis | 1 | 2019 | 58 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2018 | 3 | 0.040 |
Why?
|
Cote d'Ivoire | 2 | 2010 | 2 | 0.040 |
Why?
|
Spinal Fusion | 1 | 2019 | 71 | 0.040 |
Why?
|
Cleft Palate | 1 | 2019 | 72 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2010 | 401 | 0.040 |
Why?
|
Atrophy | 1 | 2018 | 40 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2018 | 178 | 0.040 |
Why?
|
Patient Readmission | 1 | 2019 | 242 | 0.040 |
Why?
|
Anti-Infective Agents | 2 | 2009 | 111 | 0.040 |
Why?
|
Maryland | 1 | 2016 | 34 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2017 | 99 | 0.040 |
Why?
|
Role | 1 | 2016 | 10 | 0.040 |
Why?
|
Emergency Treatment | 1 | 2016 | 33 | 0.040 |
Why?
|
Gene Dosage | 1 | 2016 | 92 | 0.040 |
Why?
|
Length of Stay | 1 | 2019 | 683 | 0.030 |
Why?
|
Recurrence | 1 | 2018 | 692 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 217 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2016 | 195 | 0.030 |
Why?
|
Rural Population | 1 | 2020 | 597 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 141 | 0.030 |
Why?
|
Blood Pressure | 1 | 2018 | 586 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 251 | 0.030 |
Why?
|
Kidney | 1 | 2019 | 821 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 580 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2016 | 742 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 638 | 0.030 |
Why?
|
Transcription Factors | 1 | 2016 | 622 | 0.030 |
Why?
|
Prognosis | 1 | 2018 | 2126 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 1504 | 0.020 |
Why?
|
South Africa | 1 | 2009 | 20 | 0.020 |
Why?
|
Decision Trees | 1 | 2009 | 25 | 0.020 |
Why?
|
HIV-1 | 1 | 2010 | 72 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2007 | 1 | 0.020 |
Why?
|
Jamaica | 1 | 2007 | 9 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 12 | 0.020 |
Why?
|
Boston | 1 | 2007 | 14 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2007 | 96 | 0.020 |
Why?
|
Toxoplasmosis | 1 | 2007 | 15 | 0.020 |
Why?
|
Morbidity | 1 | 2007 | 149 | 0.020 |
Why?
|
Siblings | 1 | 2007 | 38 | 0.020 |
Why?
|
Malaria | 1 | 2007 | 37 | 0.020 |
Why?
|
Disease Progression | 1 | 2009 | 915 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 430 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2007 | 105 | 0.020 |
Why?
|
Mycoses | 1 | 2007 | 162 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 426 | 0.020 |
Why?
|
Models, Statistical | 1 | 2006 | 258 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 922 | 0.010 |
Why?
|